Inhibition of enkephalinase activity attenuates naloxone-precipitated withdrawal symptoms
- 1 January 1987
- journal article
- research article
- Published by Elsevier in General Pharmacology: The Vascular System
- Vol. 18 (1) , 103-105
- https://doi.org/10.1016/0306-3623(87)90179-0
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Differential epileptogenic potentials of selective? and? opiate receptor agonistsJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1983
- Prolonged Exposure to Nitrous Oxide Decreases Opiate Receptor Density in Rat BrainstemAnesthesiology, 1982
- Peptidase inhibitors reduce opiate narcotic withdrawal signs, including seizure activity, in the ratBrain Research, 1982
- A comparison of the effects of morphine sulphate and nitrous oxide analgesia on chronic pain states in manJournal of the Neurological Sciences, 1981
- Opiate Effects After Adrenocorticotropin or β-Endorphin Injection in the Periaqueductal Gray Matter of RatsScience, 1978
- Stereospecific and Nonstereospecific Effects of (+)- and (—)-Morphine: Evidence for a New Class of Receptors?Science, 1977
- Endogenous opioid peptides: multiple agonists and receptorsNature, 1977
- The C-Fragment of β-Lipotropin: An Endogenous Neuroleptic or Antipsychotogen?Science, 1976
- Sites of action of morphine involved in the development of physical dependence in ratsPsychopharmacology, 1976
- Development of physical dependence on morphine in respect to time and dosage and quantification of the precipitated withdrawal syndrome in ratsPsychopharmacology, 1973